“I got evicted from my apartment in the summer of 2011. I was…

“I got evicted from my apartment in the summer of 2011. I was working on commission as a real estate broker, and I hadn’t made a deal in a long time. I had master keys to a bunch of vacant apartments, so I slept in those for a while. But that came to an end when two prospective tenants walked in on me buck-naked at a unit in Harlem. I got out of the shower, and the superintendent was standing there with two African guys. Luckily they didn’t report me. After that I tried sleeping in the office. That worked for a couple years. My colleagues saw me so much that they joked about me sleeping there. They had no idea it was true. But they fired me for good in 2013 and deactivated my entry card. That’s when I started sleeping outside. I bought a gym membership so at least I’d have a place to shower. Last winter was the worst. The cold would get through the sleeping bag and I’d wake up feeling like somebody had hit my hands with a hammer. All night I’d pray for 6 AM because that’s when my gym would open.”

Source: “I got evicted from my apartment in the summer of 2011. I was…

Republican candidate Carson says Muslims unfit to be U.S. president | Reuters

Speaking to NBC on Sunday, Trump was asked whether he’d accept a Muslim president, and replied: “Some people have said it already happened.”

Source: Republican candidate Carson says Muslims unfit to be U.S. president | Reuters

A Huge Overnight Increase in a Drug’s Price Raises Protests – The New York Times

Worst kind of greed – bleeding sick people –

Daraprim, which is also used to treat malaria, was approved by the F.D.A. in 1953 and has long been made by GlaxoSmithKline. Glaxo sold United States marketing rights in 2010 to CorePharma. Last year, Impax Laboratories agreed to buy Core and affiliated companies for $700 million. In August, Impax sold Daraprim to Turing for $55 million, a deal announced the same day Turing said it had raised $90 million from Mr. Shkreli and other investors in its first round of financing.Daraprim cost only about $1 per tablet several years ago, but went up sharply after CorePharma acquired it. According to IMS Health, which tracks prescriptions, sales of the drug jumped to $6.3 million in 2011 from $667,000 in 2010, even as prescriptions held steady at about 12,700. In 2014, after further price increases, sales were $9.9 million, as the number of prescriptions shrank to 8,821. The figures do not include inpatient use in hospitals.Turing’s price increase could bring sales to tens or even hundreds of millions of dollars a year if use remains constant. Medicaid and certain hospitals will be able to get the drug inexpensively under federal rules for discounts and rebates. But private insurers, Medicare and hospitalized patients would have to pay closer to the list price.

Source: A Huge Overnight Increase in a Drug’s Price Raises Protests – The New York Times